Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04782947 · ClinicalTrials.gov registry record · Phase 2

Epidural Stimulation and Resistance Training After SCI

A Phase 2 study of Spinal Cord Injuries, sponsored by United States Department of Defense.

Recruiting
Registry status
Phase 2
Development phase
20
Enrollment target
1
Study location

NCT04782947: Recruiting Phase 2 study of Spinal Cord Injuries, sponsored by United States Department of Defense.

NCT04782947 is a Phase 2 study of Spinal Cord Injuries that is actively recruiting participants, run by United States Department of Defense. The registered enrollment target is 20 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04782947, a Phase 2 study of Spinal Cord Injuries, is actively recruiting participants, sponsored by United States Department of Defense.

RECRUITING
Registry status
Phase 2
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Spinal cord injury (SCI) is a devastating health problem for tens of thousands of military personnel, Veterans and civilians annually. Many persons with SCI must use a wheelchair for their entire life. A new scientific breakthrough called "lumbosacral epidural stimulation" or "ES" can help people with SCI to stand, step and even walk again. At present, for ES to work, people must train with a specialized treadmill that requires several other qualified personnel to train them, which makes it hard for many people with SCI to benefit from this technology. On the other hand, there are wearable "robot suits" that can be used with ES, which would make it easier to use. Our research team has already used this "ES Robot Suit" for 3 months in one person with tetraplegia and showed remarkable improvements in motor control. Furthermore, the investigators are aiming to enhance overground motor recovery by adding 6 months of resistance training (RT). The addition of RT will likely to enhance muscle quality as indicated by increasing lean mass, peak torque and increase sensory flux to the central nervous system. Other additional benefits may include improvement in cardiovascular profile and bladder functions. The specific objectives of the current proposal are to compare the impact of EAW+ES following improving lower extremity muscle quality compared to those who will only undergo EAW+ ES without conducting RT on motor recovery, cardio-metabolic health and bladder control in persons with complete SCI. At the conclusion of the current proposal, the work will be readily available for translation into clinical setting to serve Veterans and Civilian survivors with SCI.

Primary Outcome

The investigators will measure the speed of walking and the time elapsed during 10 meter distance.

Conditions Studied

Interventions

  • DEVICE Exoskeletal assisted walking
  • DEVICE Epidural Stimulation
  • PROCEDURE Resistance Training
  • DEVICE delayed-ES
  • PROCEDURE no-Resistance training

Study Locations (1)

Virginia

  • Hunter Holmes McGuire VA Medical Center - Richmond

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-02-03
Est. Completion 2026-05-31
Phase Phase 2

What NCT04782947 shows while recruiting

NCT04782947 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (67% lower).

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 5 interventions - of which Exoskeletal assisted walking is the first listed.

NCT04782947 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT04782947 about?

NCT04782947 is a clinical study titled "Epidural Stimulation and Resistance Training After SCI". Spinal cord injury (SCI) is a devastating health problem for tens of thousands of military personnel, Veterans and civilians annually. Many persons with SCI must use a wheelchair for their entire life. A new scientific breakthrough called "lumbosacral epidural stimulation" or "ES" can help people wi...

What is the current status of trial NCT04782947?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2021-02-03. Estimated completion is 2026-05-31.

What conditions does trial NCT04782947 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT04782947?

The interventions under investigation include: Exoskeletal assisted walking (DEVICE), Epidural Stimulation (DEVICE), Resistance Training (PROCEDURE), delayed-ES (DEVICE), no-Resistance training (PROCEDURE).

Who is sponsoring clinical trial NCT04782947?

This trial is sponsored by United States Department of Defense, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04782947 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04782947's enrollment target sits among peer trials

20 126th of 202 higher than 66 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT04782947, the US trial registry maintained by the National Library of Medicine. NCT04782947 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.